Novo Nordisk announced it will change its operating name to 'Novo' and adopt a new cultural framework to strengthen its position in the GLP-1 drug market · Azimuth Daily
Novo Nordisk announced it will change its operating name to 'Novo' and adopt a new cultural framework to strengthen its position in the GLP-1 drug market.
Items older than 7 days — their verdicts, sources and coverage history — are part of the Azimuth Daily record and available to signed-in readers.